Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: F. Jay Abella, III who wrote (3608)	6/5/1998 9:03:00 AM
From: Michael Brey	Read Replies (1) \| Respond to of 3906

Funny, they have the same goals every year. That is almost to a line item their agenda from november of 96. MILESTONES FOR THE NEXT 12 MONTHS 1.Begin Phase II clinical trials for male sexual dysfunction treatment product 2.Form strategic alliances, joint venture arrangements, licensing and distribution or, research and development agreements and other collaborative arrangements with a major pharmaceutical partner with particular emphasis on the ED product, 3.Advance the female dysfunction and psoriasis products to clinical trials. 4.Rectify, resolve or settle outstanding legal matters 5.List on a national exchange for the common stock. 6.Augment current patent portfolio